HIGHLIGHTS
- who: Chemotherapy, and Reduces, Neoadjuvant from the therapeutic or surgical intervention (5)These challenges emphasize a critical need for new strategies to specifically target metastatic cancer cells, including , Department of Pathology and Molecular Medicine, Queen`s University, Kingston, Ontario, Canada. , Division of Cancer Biology and Genetics, Queen`s Cancer Research Institute have published the article: OPEN ACCESS, in the Journal: (JOURNAL) of 08/04/2023
- what: The authors show that anti-ezrin treatment disease largely due to the development of resistance. In of anti-ezrin treatment in modulating response to in breast cancer cells as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.